These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2401420

  • 1. Ocular toxicity of multiple intravitreal DHPG injections.
    Yoshizumi MO, Lee D, Vinci V, Fajardo S.
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):350-5. PubMed ID: 2401420
    [Abstract] [Full Text] [Related]

  • 2. Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir.
    Berthe P, Baudouin C, Garraffo R, Hofmann P, Taburet AM, Lapalus P.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1038-45. PubMed ID: 8125715
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal toxicity of garenoxacin.
    Esfahani MR, Kazi AA, Peyman GA, Dellacroce JT, Aydin E.
    Retina; 2006 Feb; 26(2):182-6. PubMed ID: 16467675
    [Abstract] [Full Text] [Related]

  • 4. Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.
    Diets-Ouwehand JJ, de Keizer RJ, Vrensen GF, Groen-Jansen S, van Best JA.
    Graefes Arch Clin Exp Ophthalmol; 1992 Feb; 230(5):488-95. PubMed ID: 1521818
    [Abstract] [Full Text] [Related]

  • 5. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E, Del Sole MJ, Torbidoni A, Fandino A, Asprea M, Croxatto JO, Chantada GL, Bramuglia GF, Schaiquevich P.
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L, Hostetler KY, Chaidhawangul S, Gardner MF, Beadle JR, Keefe KS, Bergeron-Lynn G, Severson GM, Soules KA, Mueller AJ, Freeman WR.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [Abstract] [Full Text] [Related]

  • 7. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.
    Dolnak DR, Munguia D, Wiley CA, De Clercq E, Bergeron-Lynn GL, Boscher C, Connor JD, Sherwood C, Capparelli E, Armani R.
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMP.
    Shakiba S, Assil KK, Listhaus AD, Munguia D, Flores-Aguilar M, Vuong C, Wiley CA, Tolman RL, Karkas JD, Bergeron-Lynn G.
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2903-10. PubMed ID: 8395482
    [Abstract] [Full Text] [Related]

  • 9. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial.
    Díaz-Llopis M, Martos MJ, España E, Cervera M, Vila AO, Navea A, Molina FJ, Romero FJ.
    Doc Ophthalmol; 1992 Sep; 82(4):297-305. PubMed ID: 1339115
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis.
    Young S, Morlet N, Besen G, Wiley CA, Jones P, Gold J, Li Y, Freeman WR, Coroneo MT.
    Ophthalmology; 1998 Aug; 105(8):1404-10. PubMed ID: 9709750
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis.
    Ussery FM, Gibson SR, Conklin RH, Piot DF, Stool EW, Conklin AJ.
    Ophthalmology; 1988 May; 95(5):640-8. PubMed ID: 2845321
    [Abstract] [Full Text] [Related]

  • 13. Toxicity and clearance of intravitreal cefotetan.
    Philipp W, Schmid K, Steiner HJ, Pümpel B, Allerberger F, Aichberger HP, Mayer W.
    Graefes Arch Clin Exp Ophthalmol; 1990 May; 228(5):475-80. PubMed ID: 2227495
    [Abstract] [Full Text] [Related]

  • 14. Retinal toxicity of intravitreal tenecteplase in the rabbit.
    Rowley SA, Vijayasekaran S, Yu PK, McAllister IL, Yu DY.
    Br J Ophthalmol; 2004 Apr; 88(4):573-8. PubMed ID: 15031179
    [Abstract] [Full Text] [Related]

  • 15. [Retinal toxicity of intravitreal doxycycline. A pilot study].
    Aydin E, Kazi AA, Peyman GA, Esfahani MR, Muñoz-Morales A, Kivilcim M, Caro-Magdaleno M.
    Arch Soc Esp Oftalmol; 2007 Apr; 82(4):223-8. PubMed ID: 17443427
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retinal toxicity of 6-methoxypurine arabinoside (ara-M). A new selective and potent inhibitor of varicella-zoster virus.
    Karaçorlu S, Peyman GA, Karaçorlu M, Dunlap W, Soike KF.
    Retina; 1992 Apr; 12(3):261-4. PubMed ID: 1329170
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ocular toxicity of intravitreal tacrolimus.
    Passos E, Genaidy MM, Peyman GA.
    Ophthalmic Surg Lasers; 2002 Apr; 33(2):140-4. PubMed ID: 11942546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.